advertisement
11.1 General management, indication (812)
Showing records 1 to 25
Display only abstracts from IGR 21-4 in classification 11.1 General management, indication
Search within classification 11.1 General management, indication94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Bengtsson B
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
King AJ
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ofei-Palm CNK; Tagoe NN
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Hudson J
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Lindén C
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Jatoe D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Fernie G
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Heijl A; Andersson-Geimer S; Andersson-Geimer S
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Agyare A
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Kernohan A
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Azuara-Blanco A
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ankrah D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627 (IGR: 22-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Aspberg J; Jóhannesson G
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; Maclennan G;
British Medical Journal (Clinical Research Edition) 2021; 373: n1014 (IGR: 22-2)
92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi R
Journal of Ophthalmology 2021; 2021: 5013529 (IGR: 22-1)
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Qureshi R
Ophthalmology. Glaucoma 2021; 0: (IGR: 22-1)
92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
MacIver S
Clinical and Experimental Optometry 2021; 104: 350-366 (IGR: 22-1)
92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Bro T
Acta Ophthalmologica 2021; 99: e1442-e1448 (IGR: 22-1)
91911 Advances in medical therapy for glaucoma
Ostler E
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Lin YH
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)
91905 Glaucoma
Kang JM; Tanna AP
The Medical clinics of North America 2021; 105: 493-510 (IGR: 22-1)
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Su WW
Journal of Glaucoma 2021; 30: 690-696 (IGR: 22-1)
92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Wickström K
Acta Ophthalmologica 2021; 99: e1442-e1448 (IGR: 22-1)
